SOURCE: Leerink Swann & Co.

October 06, 2005 11:59 ET

Leerink Swann & Company Initiates Coverage of Varian Medical Systems, Inc. (NYSE: VAR)

BOSTON, MA -- (MARKET WIRE) -- October 6, 2005 -- This morning, Senior Medical Device Analyst, Jason Wittes, initiated coverage of Varian Medical Systems, Inc. (NYSE: VAR) with an Outperform rating. His investment rating is based on his belief that Varian, the entrenched leader in radiation oncology, is on the cusp of a new product cycle with Image Guided Radiation Therapy and should grow earnings at a 17% compound annual rate over the next 3 to 5 years.

About Varian Medical Systems, Inc.

Varian Medical Systems, Inc. (NYSE: VAR) designs and manufactures radiation equipment for treating cancer as well as X-ray tubes and flat-panel digital subsystems for medical, scientific, and industrial applications. The company has manufacturing operations in North America and Europe and is headquartered in Palo Alto, California.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564
    www.leerink.com